Biocryst Pharmaceuticals Inc (BCRX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biocryst Pharmaceuticals Inc (BCRX)

BCRX 7.080

+0.7%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (67)	1/22/2007 7:23:58 PM
From: kenhott	Read Replies (1) of 269

Clue I don't have but BCRX has no near term events to keep someone from being aggressive. Fodosine: pivotal phase 2b SPA just started. Oral CLL phase 2 is small, single center, open label and taking forever. IV phase 1/2 B-ALL interim data Dec 06 so nothing for awhile. Oral phase 1 CTCL started Oct 04. Peramivir nothing. BCX-4208 phase 2 to start. Don't expect partnership for Fodosine in USA. BCX-4208 is Roche. Don't expect partnership for Peramivir. 4678 in pre-clin and not scaring people. Bird flu is last year news unless it escalates. Buyers waiting. And maybe some sellers have an itch they want to scratch. I am sure there is more going on than I can guess.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next